Infinity Pharma INFI announced additional details on the design of its phase II MARIO-8 study, evaluating eganelisib for squamous cell cancer of the head and neck (SCCHN). Shares of the company were ...

LONDON--(BUSINESS WIRE)--Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on market assessment study. This success ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (INFI) today announced topline data from its Phase 2 study of retaspimycin hydrochloride (HCl), a potent and selective heat shock ...

INFINITI continues to bring thoughtful hospitality to every aspect of the client experience, and has been recognized for its focus on vehicle quality in the J.D. Power 2024 U.S. Initial Quality ...

Infiniti released a teaser of its QX60 Monograph three-row luxury SUV, set for a global reveal that for U.S. audiences falls on the evening of Sept. 24. The animated teaser shows horizontal lighting ...